Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates

OBJECTIVES:. High velocity therapy (HVT), a form of high-flow oxygen therapy, utilizing a small-bore nasal cannula has been widely used in acute care settings. A new dual-prong (newDP) cannula made using more comfortable material and a single-prong (SP) cannula were evaluated to compare comfort and...

Full description

Saved in:
Bibliographic Details
Main Authors: Charles Atwood, MD, Jigme Sethi, MD, Amy Bergeski, MHA, RRT-NPS, George C. Dungan, II, MPhil (Med), Leonithas I. Volakis, MS, PhD, Jessica S. Whittle, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2025-02-01
Series:Critical Care Explorations
Online Access:http://journals.lww.com/10.1097/CCE.0000000000001209
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849717048555339776
author Charles Atwood, MD
Jigme Sethi, MD
Amy Bergeski, MHA, RRT-NPS
George C. Dungan, II, MPhil (Med)
Leonithas I. Volakis, MS, PhD
Jessica S. Whittle, MD, PhD
author_facet Charles Atwood, MD
Jigme Sethi, MD
Amy Bergeski, MHA, RRT-NPS
George C. Dungan, II, MPhil (Med)
Leonithas I. Volakis, MS, PhD
Jessica S. Whittle, MD, PhD
author_sort Charles Atwood, MD
collection DOAJ
description OBJECTIVES:. High velocity therapy (HVT), a form of high-flow oxygen therapy, utilizing a small-bore nasal cannula has been widely used in acute care settings. A new dual-prong (newDP) cannula made using more comfortable material and a single-prong (SP) cannula were evaluated to compare comfort and functionality as measured by relief of dyspnea of patients with chronic obstructive pulmonary disease (COPD) receiving HVT therapy. DESIGN:. Randomized crossover evaluation. SETTING:. Outpatient and in patient critical care setting. PATIENTS:. Patients with hypercapnic COPD presenting with dyspnea above baseline. INTERVENTIONS:. HVT therapy was provided using an existing HVT dual-prong nasal cannula (traditional) to determine the most efficacious flow rate. Patients were then randomized to receive either the newDP cannula, or the SP cannula, and retitrated for optimal flow rate. During each session of therapy, Rated Perceived Dyspnea (RPD) scores, vital signs, transcutaneous carbon dioxide partial pressure (PTCco2) levels, and clinician/ patient perceptions were documented. MEASUREMENTS AND MAIN RESULTS:. Of 31 enrolled, 26 patients completed the trial. The median flow rate that relieved dyspnea for the traditional, newDP, and SP cannulas were 25 L/min (20–30 L/min), 25 L/min (19.1–30 L/min), and 15 L/min (13–17 L/min), respectively. The change in RPD from baseline for traditional, newDP, and SP were –1 (–1 to 0), –1 (–2 to –1), and –1 (–2 to –1). Change in RPD from baseline for newDP and SP compared with the traditional cannula was significantly different (p = 0.044 and p = 0.01, respectively). Changes in vital signs and PTCco2 were similar between the three cannula types compared with baseline. The SP cannula provided comparable therapeutic efficacy at significantly lower flow rates (traditional vs. SP; p < 0.0001 and newDP vs. SP; p < 0.0001). CONCLUSIONS:. The new cannula designs provided comparable relief of dyspnea. The single-prong cannula provided comparable efficacy at significantly lower flow rates (traditional vs. SP; p < 0.0001 and newDP vs. SP; p < 0.0001). The use of a single-prong cannula with HVT warrants further study.
format Article
id doaj-art-e42267cc259e4e1eb7110c1966f3ce21
institution DOAJ
issn 2639-8028
language English
publishDate 2025-02-01
publisher Wolters Kluwer
record_format Article
series Critical Care Explorations
spelling doaj-art-e42267cc259e4e1eb7110c1966f3ce212025-08-20T03:12:47ZengWolters KluwerCritical Care Explorations2639-80282025-02-0172e120910.1097/CCE.0000000000001209202502000-00011Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow RatesCharles Atwood, MD0Jigme Sethi, MD1Amy Bergeski, MHA, RRT-NPS2George C. Dungan, II, MPhil (Med)3Leonithas I. Volakis, MS, PhD4Jessica S. Whittle, MD, PhD51 Pulmonary and Sleep Medicine, VA Pittsburgh Healthcare System, Pittsburgh, PA.2 University of Tennessee Health Science Center, Chattanooga, TN.3 Vapotherm, Exeter, NH.3 Vapotherm, Exeter, NH.3 Vapotherm, Exeter, NH.3 Vapotherm, Exeter, NH.OBJECTIVES:. High velocity therapy (HVT), a form of high-flow oxygen therapy, utilizing a small-bore nasal cannula has been widely used in acute care settings. A new dual-prong (newDP) cannula made using more comfortable material and a single-prong (SP) cannula were evaluated to compare comfort and functionality as measured by relief of dyspnea of patients with chronic obstructive pulmonary disease (COPD) receiving HVT therapy. DESIGN:. Randomized crossover evaluation. SETTING:. Outpatient and in patient critical care setting. PATIENTS:. Patients with hypercapnic COPD presenting with dyspnea above baseline. INTERVENTIONS:. HVT therapy was provided using an existing HVT dual-prong nasal cannula (traditional) to determine the most efficacious flow rate. Patients were then randomized to receive either the newDP cannula, or the SP cannula, and retitrated for optimal flow rate. During each session of therapy, Rated Perceived Dyspnea (RPD) scores, vital signs, transcutaneous carbon dioxide partial pressure (PTCco2) levels, and clinician/ patient perceptions were documented. MEASUREMENTS AND MAIN RESULTS:. Of 31 enrolled, 26 patients completed the trial. The median flow rate that relieved dyspnea for the traditional, newDP, and SP cannulas were 25 L/min (20–30 L/min), 25 L/min (19.1–30 L/min), and 15 L/min (13–17 L/min), respectively. The change in RPD from baseline for traditional, newDP, and SP were –1 (–1 to 0), –1 (–2 to –1), and –1 (–2 to –1). Change in RPD from baseline for newDP and SP compared with the traditional cannula was significantly different (p = 0.044 and p = 0.01, respectively). Changes in vital signs and PTCco2 were similar between the three cannula types compared with baseline. The SP cannula provided comparable therapeutic efficacy at significantly lower flow rates (traditional vs. SP; p < 0.0001 and newDP vs. SP; p < 0.0001). CONCLUSIONS:. The new cannula designs provided comparable relief of dyspnea. The single-prong cannula provided comparable efficacy at significantly lower flow rates (traditional vs. SP; p < 0.0001 and newDP vs. SP; p < 0.0001). The use of a single-prong cannula with HVT warrants further study.http://journals.lww.com/10.1097/CCE.0000000000001209
spellingShingle Charles Atwood, MD
Jigme Sethi, MD
Amy Bergeski, MHA, RRT-NPS
George C. Dungan, II, MPhil (Med)
Leonithas I. Volakis, MS, PhD
Jessica S. Whittle, MD, PhD
Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates
Critical Care Explorations
title Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates
title_full Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates
title_fullStr Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates
title_full_unstemmed Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates
title_short Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates
title_sort effect of single prong cannula design with high velocity therapy comparable efficacy at lower gas flow rates
url http://journals.lww.com/10.1097/CCE.0000000000001209
work_keys_str_mv AT charlesatwoodmd effectofsingleprongcannuladesignwithhighvelocitytherapycomparableefficacyatlowergasflowrates
AT jigmesethimd effectofsingleprongcannuladesignwithhighvelocitytherapycomparableefficacyatlowergasflowrates
AT amybergeskimharrtnps effectofsingleprongcannuladesignwithhighvelocitytherapycomparableefficacyatlowergasflowrates
AT georgecdunganiimphilmed effectofsingleprongcannuladesignwithhighvelocitytherapycomparableefficacyatlowergasflowrates
AT leonithasivolakismsphd effectofsingleprongcannuladesignwithhighvelocitytherapycomparableefficacyatlowergasflowrates
AT jessicaswhittlemdphd effectofsingleprongcannuladesignwithhighvelocitytherapycomparableefficacyatlowergasflowrates